D'APICE, LUCIANA
 Distribuzione geografica
Continente #
AS - Asia 1.388
NA - Nord America 784
EU - Europa 313
SA - Sud America 236
AF - Africa 22
OC - Oceania 3
AN - Antartide 1
Totale 2.747
Nazione #
US - Stati Uniti d'America 743
SG - Singapore 543
CN - Cina 354
BR - Brasile 184
HK - Hong Kong 134
VN - Vietnam 129
KR - Corea 85
FR - Francia 69
IT - Italia 66
IN - India 33
JP - Giappone 31
DE - Germania 30
FI - Finlandia 27
GB - Regno Unito 27
NL - Olanda 25
AR - Argentina 20
CA - Canada 16
PL - Polonia 12
ID - Indonesia 11
MX - Messico 11
IL - Israele 10
AT - Austria 9
ZA - Sudafrica 9
BD - Bangladesh 8
EC - Ecuador 8
PK - Pakistan 7
RU - Federazione Russa 7
TR - Turchia 7
CO - Colombia 6
PY - Paraguay 6
SE - Svezia 6
ES - Italia 5
IQ - Iraq 5
MA - Marocco 5
PH - Filippine 5
CL - Cile 4
PA - Panama 4
UZ - Uzbekistan 4
AU - Australia 3
IE - Irlanda 3
KZ - Kazakistan 3
PE - Perù 3
PT - Portogallo 3
RO - Romania 3
SA - Arabia Saudita 3
TJ - Tagikistan 3
UA - Ucraina 3
VE - Venezuela 3
AE - Emirati Arabi Uniti 2
AL - Albania 2
BE - Belgio 2
BG - Bulgaria 2
CR - Costa Rica 2
DK - Danimarca 2
DZ - Algeria 2
GR - Grecia 2
HN - Honduras 2
JO - Giordania 2
KE - Kenya 2
KG - Kirghizistan 2
LB - Libano 2
LT - Lituania 2
TN - Tunisia 2
AQ - Antartide 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BH - Bahrain 1
BO - Bolivia 1
BW - Botswana 1
BY - Bielorussia 1
CZ - Repubblica Ceca 1
ET - Etiopia 1
GT - Guatemala 1
KH - Cambogia 1
KN - Saint Kitts e Nevis 1
LA - Repubblica Popolare Democratica del Laos 1
MN - Mongolia 1
NO - Norvegia 1
RS - Serbia 1
SI - Slovenia 1
SV - El Salvador 1
TT - Trinidad e Tobago 1
TW - Taiwan 1
UY - Uruguay 1
VC - Saint Vincent e Grenadine 1
Totale 2.747
Città #
Singapore 331
Santa Clara 188
Hefei 176
San Jose 146
Hong Kong 132
Seoul 84
Ashburn 64
Beijing 61
Lauterbourg 52
Los Angeles 49
Ho Chi Minh City 48
Dallas 42
Hanoi 27
Helsinki 20
Tokyo 20
New York 19
São Paulo 17
Rome 14
Frankfurt am Main 12
Avellino 11
Buffalo 11
Orem 11
Marigliano 9
Minamishinagawa 9
Chennai 8
Da Nang 8
Warsaw 8
Phoenix 7
Amsterdam 6
Bengaluru 6
Chicago 6
Council Bluffs 6
Montreal 6
Naples 6
Nuremberg 6
Rio de Janeiro 6
Boardman 5
Lappeenranta 5
Ninh Bình 5
Stockholm 5
Atlanta 4
Denver 4
Haiphong 4
Tashkent 4
Ankara 3
Buenos Aires 3
Campinas 3
City of London 3
Dushanbe 3
Falkenstein 3
Guangzhou 3
Guarulhos 3
Johannesburg 3
Lahore 3
Lima 3
Lisbon 3
London 3
Munich 3
Panama City 3
Poplar 3
Portsmouth 3
Quito 3
Santiago 3
Santo André 3
Seattle 3
São Bernardo do Campo 3
Thái Nguyên 3
Vienna 3
Ahmedabad 2
Algiers 2
Almaty 2
Alvorada 2
Amman 2
Asunción 2
Athens 2
Baghdad 2
Barbacena 2
Bauru 2
Belo Horizonte 2
Bishkek 2
Biên Hòa 2
Bogotá 2
Bologna 2
Brasília 2
Brooklyn 2
Brussels 2
Cape Town 2
Chapecó 2
Curitiba 2
Dhaka 2
Düsseldorf 2
Fortaleza 2
Garanhuns 2
Guayaquil 2
Houston 2
Hyderabad 2
Ipojuca 2
Jackson 2
Jeddah 2
Joinville 2
Totale 1.804
Nome #
Co-Delivery of the Human NY-ESO-1 Tumor-Associated Antigen and Alpha-GalactosylCeramide by Filamentous Bacteriophages Strongly Enhances the Expansion of Tumor-Specific CD8+ T Cells 111
Vectorized delivery of alpha-GalactosylCeramide and tumor antigen on filamentous bacteriophage fd induces protective immunity by enhancing tumor-specific T cell. 111
T cell receptors 88
HIV Vaccination: A Roadmap among Advancements and Concerns. 86
Give a selfie for women @CNR 73
Review HIV Vaccination: A Roadmap among Advancements and Concerns 72
300x100: Protagoniste per la ricerca 71
Filamentous bacteriophages targeting DEC-205 induce DC maturation and durable T cell responses in absence of adjuvants. 70
Design of cassette vectors permitting cloning of all types of human TCR variable alpha and beta regions 68
Comparative analysis of the neutralizing activity against SARS-CoV-2 Wuhan-Hu-1 strain and variants of concern: Performance evaluation of a pseudovirus-based neutralization assay 67
A preliminary investigation on hydrogel disks imbibed with enriched transfersomes as promising tool to promote the cutaneous deposition of vaccine antigens 66
Viral Emerging Diseases: Challenges in Developing Vaccination Strategies 64
Booster Dose of SARS-CoV-2 mRNA Vaccine in Kidney Transplanted Patients Induces Wuhan-Hu-1 Specific Neutralizing Antibodies and T Cell Activation but Lower Response against Omicron Variant 61
Investigation on alternative splicing in MCF-7 cells by RNA-Seq: identification and characterization of a new transcript of SEMA3F. 57
Exploiting viral sensing mediated by Toll-like receptors to design innovative vaccines 57
Arming filamentous bacteriophage, aNature-made nanoparticles, for new vaccine and immunotherapeutic strategies 56
Boosting antigen-specific T cell activation with lipid-stabilized protein nanoaggregates 55
Distinct Antigen Delivery Systems Induce Dendritic Cells' Divergent Transcriptional Response: New Insights from a Comparative and Reproducible Computational Analysis. 55
E2 multimeric scaffold for vaccine formulation: immune response by intranasal delivery and transcriptome profile of E2-pulsed dendritic cells. 54
Searching for new vaccine vectors: E2 protein from B. stearothermophilus PDH complex. 53
An Ig Transmembrane Domain Motif Improves the Function of TCRs Transduced in Human T Cells: Implications for Immunotherapy 53
ImmuNapoli 2019 51
Arming Filamentous Bacteriophage, a Nature-Made Nanoparticle, for New Vaccine and Immunotherapeutic Strategies 50
PEI-Engineered Lipid@PLGA Hybrid Nanoparticles for Multimodal Delivery of Antigens and Immune Adjuvants to the Respiratory Mucosa 49
Alternative splicing in adhesion- and motility-related genes in breast cancer 47
Vaccination with Filamentous Bacteriophages trageting DEC-205 induces DC maturation and potent anti-tumor T cell response in absence of adjuvants 45
Stimulation of Innate and Adaptive Immunity by Using Filamentous Bacteriophage fd Targeted to DEC-205. 45
Antigen delivery by filamentous bacteriophage fd displaying an anti-DEC-205 single-chain variable fragment confers adjuvanticity by triggering a TLR9-mediated immune response. 43
E2 multimeric scaffold for vaccine formulation: transcriptome analysis of pulsed dendritic cells and immune response by intranasal delivery. 41
Antigen delivery by filamentous bacteriophage fd displaying an anti-DEC-205 single-chain variable fragment confers adjuvanticity by triggering a TLR9-mediated immune response. 39
Vaccination with filamentous bacteriophages targeting DEC-205 induces DC maturation and potent anti-tumor T cell response in absence of adjuvants 39
Filamentous bacteriophage: an antigen and gene delivery system 37
Comparative analysis of new innovative vaccine formulations based on the use of procaryotic display systems 37
Targeting dendritic cells with filamentous bacteriophage fd carriers displaying anti-Dec 205 scFv bypasses the need of adjuvants 37
Co-immunization with Multimeric Scaffolds and DNA Rapidly Induces Potent Autologous HIV-1 Neutralizing Antibodies and CD8+ T Cells 34
HIV-1 Gag p17 presented as virus-like particles on the E2 scaffold from Geobacillus stearothermophilus induces sustained humoral and cellular immune responses in the absence of IFN³ production by CD4+ T cells 33
The use of filamentous bacteriophage fd to deliver MAGE-A10 or MAGE-A3 HLA-A2 restricted peptides and to induce strong anti-tumor CTL responses 33
Filamentous bacteriophages targeting DEC-205 induce DC maturation and durable T cell responses in absence of adjuvants 33
Analysis of SEMA6B gene expression in breast cancer: Identification of a new isoform. 32
TLR-9 dependent dendritic cell activation by filamentous bacteriophage targeting DEC-205. 32
Filamentous bacteriophages targeting DEC-205 induce dendritic cell maturation and potent T cell response in absence of adjuvants 31
Massive-scale RNA-Sequencing of Bone Marrow derived Dendritic Cells exposed to different antigen display systems. 31
Induction of human NK cell-mediated cytotoxicity by CD40 triggering on antigen presenting cells. 30
New recombinant vaccine based on filamentous bacteriophage fd particles targeting DC 29
Filamentous bacteriophages targeting DEC-205 induce DC maturation and durable T cell responses in absence of adjuvants 29
Vaccination with filamentous bacteriophages targeting DEC-205 induces DC maturation and potent anti-tumor T cell response in absence of adjuvants 29
Recognition of HIV-derived B and T cell epitopes displayed on filamentous phages. 29
ImmuNapoli 2016 27
Co-immunization with Multimeric Scaffolds and DNA Rapidly Induces Potent Autologous HIV-1 27
Co-immunization with multimeric E2 scaffolds and DNA rapidly induces potent autologous HIV-1 neutralizing antibodies and CD8+ T cells 27
Massive-Scale RNA-Seq Analysis of Non Ribosomal Transcriptome in Human Trisomy 21 26
Filamentous bacteriophages targeting DEC-205 induce DC-maturation and strong T cell responses in absence of adjuvants. 26
Filamentous bacteriophages targeting DEC-205 induce DC-maturation and strong T cell responses in absence of adjuvants. 26
E2 multimeric scaffolds displaying HIV-1 Envelope regions sustain specific neutralizing antibody and T cell responses when combined with gp160 plasmid DNA 26
Intranasal immunization with E2 multimeric scaffolds displaying the HIV-1 third hypervariable region induces V3-specific IgA antibodies as well as CD4+ T cell responses 26
Comparative analysis of innovative vaccine formulations based on the use of procaryotic display systems. 25
Identification of a new subset of cells exhibiting dendritic phenotypes in patients affected by breast proliferative disorders. 25
Human naive CD4 T-cell clones specific for HIV envelope persist for years in vivo in the absence of antigenic challenge 25
Coimmunizzation with multimeric E2 scaffolds and DNA rapidly induces potent autologous HIV-1 neutralizing antibodies and CD8+ T cells 22
Massive-scale RNA-seq analysis of non ribosomal transcriptome in human Trisomy 21. 22
RNA-seq: from computational challenges to biological insights 20
Massive-scale analysis of rRNA-depleted transcriptional landscape in human trisomy 21 20
Massive-scale RNA-Seq analysis of non ribosomal transcriptome in human trisomy 21 " 19
Totale 2.802
Categoria #
all - tutte 8.188
article - articoli 5.061
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 103
Totale 13.352


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/202444 0 0 0 0 0 0 0 1 2 2 26 13
2024/20251.006 7 4 74 37 194 37 10 91 36 30 253 233
2025/20261.752 104 174 204 289 281 108 242 51 78 139 82 0
Totale 2.802